Print

ANRS VAC 01

Trial Details:

I Completed
French National Agency for Research on AIDS and viral hepatitis (ANRS)
ALVAC vCP125,gp160 Vaccine (Immuno-AG)
RandD/trials/Lists/ClinicalTrialsList
Canarypox Env gp160 B MN; Protein gp160 env B LAI, MN